Your browser doesn't support javascript.
loading
Stiff person spectrum disorder diagnosis, misdiagnosis, and suggested diagnostic criteria.
Chia, Nicholas H; McKeon, Andrew; Dalakas, Marinos C; Flanagan, Eoin P; Bower, James H; Klassen, Bryan T; Dubey, Divyanshu; Zalewski, Nicholas L; Duffy, Dustin; Pittock, Sean J; Zekeridou, Anastasia.
Afiliación
  • Chia NH; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
  • McKeon A; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
  • Dalakas MC; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
  • Flanagan EP; Center of MS and Autoimmune Neurology, Mayo Clinic, Rochester, Minnesota, USA.
  • Bower JH; Department of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Klassen BT; Neuroimmunology Unit, National and Kapodistrian University of Athens, Athens, Greece.
  • Dubey D; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
  • Zalewski NL; Center of MS and Autoimmune Neurology, Mayo Clinic, Rochester, Minnesota, USA.
  • Duffy D; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
  • Pittock SJ; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
  • Zekeridou A; Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
Ann Clin Transl Neurol ; 10(7): 1083-1094, 2023 07.
Article en En | MEDLINE | ID: mdl-37212351
BACKGROUND: Stiff person spectrum disorder (SPSD) is heterogeneous, and accurate diagnosis can be challenging. METHODS: Patients referred for diagnosis/suspicion of SPSD at the Mayo Autoimmune Neurology Clinic from July 01, 2016, to June 30, 2021, were retrospectively identified. SPSD diagnosis was defined as clinical SPSD manifestations confirmed by an autoimmune neurologist and seropositivity for high-titer GAD65-IgG (>20.0 nmol/L), glycine-receptor-IgG or amphiphysin-IgG, and/or confirmatory electrodiagnostic studies (essential if seronegative). Clinical presentation, examination, and ancillary testing were compared to differentiate SPSD from non-SPSD. RESULTS: Of 173 cases, 48 (28%) were diagnosed with SPSD and 125 (72%) with non-SPSD. Most SPSD were seropositive (41/48: GAD65-IgG 28/41, glycine-receptor-IgG 12/41, amphiphysin-IgG 2/41). Pain syndromes or functional neurologic disorder were the most common non-SPSD diagnoses (81/125, 65%). SPSD patients more commonly reported exaggerated startle (81% vs. 56%, p = 0.02), unexplained falls (76% vs. 46%, p = 0.001), and other associated autoimmunity (50% vs. 27%, p = 0.005). SPSD more often had hypertonia (60% vs. 24%, p < 0.001), hyperreflexia (71% vs. 43%, p = 0.001), and lumbar hyperlordosis (67% vs. 9%, p < 0.001) and less likely functional neurologic signs (6% vs. 33%, p = 0.001). SPSD patients more frequently had electrodiagnostic abnormalities (74% vs. 17%, p < 0.001), and at least moderate symptomatic improvement with benzodiazepines (51% vs. 16%, p < 0.001) or immunotherapy (45% vs. 13% p < 0.001). Only 4/78 non-SPSD patients who received immunotherapy had alternative neurologic autoimmunity. INTERPRETATION: Misdiagnosis was threefold more common than confirmed SPSD. Functional or non-neurologic disorders accounted for most misdiagnoses. Clinical and ancillary testing factors can reduce misdiagnosis and exposure to unnecessary treatments. SPSD diagnostic criteria are suggested.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Autoanticuerpos / Síndrome de la Persona Rígida Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Ann Clin Transl Neurol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Autoanticuerpos / Síndrome de la Persona Rígida Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Ann Clin Transl Neurol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos